Samsung Bioepis Quiet On Launch Date After EU Soliris Biosimilar Approval

Follows Recent Approval For Amgen’s Bekemv Eculizumab Biosimilar

 
• By Dean Rudge

Samsung Bioepis responded to Generics Bulletin enquiries following its EU-wide approval for a biosimilar to AstraZeneca’s Soliris.

Europe map (timyee/Shutterstock.com)
• Source: Shutterstock

More from Biosimilars

More from Products